J. P. M. Finberg

Statistics

Publications

Citations

4.2K

H-Index

Active since

1970

Affiliations

Rappaport Family Institute for Research in the Medical Sciences(Current)

Technion – Israel Institute of Technology

Rambam Health Care Campus

National Institute of Neurological Disorders and Stroke

National Institutes of Health

J. P. M. Finberg is an author at Rappaport Family Institute for Research in the Medical Sciences specializing in neuropharmacology, medicine, and pharmacology.

ORCID

Publications per year

1970–2020

Publications

Rasagiline [N‐propargyl‐1R(+)‐aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B

Moussa B. H. Youdim, Aviva Gross, J. P. M. Finberg · British Journal of Pharmacology · 2001 · 340 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons

Dorit Ben‐Shachar, G. Eshel, J. P. M. Finberg et al. · Journal of Neurochemistry · 1991 · 297 citations

Life Sciences, Neuroscience, Pharmacology +17

Copper pathology in vulnerable brain regions in Parkinson's disease

Katherine M. Davies, Sylvain Bohic, Asunción Carmona et al. · Neurobiology of Aging · 2013 · 243 citations · Full text

Life Sciences, Neurology, Neuroscience +14

Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug

Chantal Moret, Marie Charvéron, J. P. M. Finberg et al. · Neuropharmacology · 1985 · 173 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Effect of Long‐Term Treatment with Selective Monoamine Oxidase A and B Inhibitors on Dopamine Release from Rat Striatum In Vivo

Itschak Lamensdorf, Moussa B. H. Youdim, J. P. M. Finberg · Journal of Neurochemistry · 1996 · 131 citations

Medicine, Neuroscience, Pharmacology +16

1–5 of 82